ViewRay® to Participate in Upcoming Investor Conferences
ViewRay, Inc. (NASDAQ: VRAY) announced participation in three virtual investor conferences scheduled for September 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ViewRay, Inc. (NASDAQ: VRAY) announced participation in three virtual investor conferences scheduled for September 2020. The first event is the Cantor Virtual Global Healthcare Conference on September 16, followed by the Morgan Stanley 18th Annual Global Healthcare Conference on September 18 at 11:00 am ET. Finally, ViewRay will attend the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23 at 2:30 pm ET. Replays of the fireside chats will be available for 14 days post-presentation.
Details
News Market Reaction – VRAY
The recorded move for VRAY in the trading session of this news was +0.72%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CLEVELAND, Sept. 4, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in three upcoming virtual investor conferences.
Event: | Cantor Virtual Global Healthcare Conference |
Format: | Virtual 1x1 Meetings |
Date: | Wednesday, September 16, 2020 |
Event: | Morgan Stanley 18th Annual Global Healthcare Conference |
Format: | Virtual Fireside Chat & 1x1 Meetings |
Date: | Friday, September 18, 2020 |
Time: | 11:00 am ET |
Link: | http://investors.viewray.com/events-and-presentations/upcoming-events |
Event: | Oppenheimer Fall Healthcare Life Sciences & MedTech Summit |
Format: | Virtual Fireside Chat & 1x1 Meetings |
Date: | Wednesday, September 23, 2020 |
Time: | 2:30 pm ET |
Link: |
A replay of the fireside chats will be available for 14 days after the date of the presentation at http://investors.viewray.com/events-and-presentations/upcoming-events.
About ViewRay
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/viewray-to-participate-in-upcoming-investor-conferences-301124365.html
SOURCE ViewRay, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.